Jonathan Popler, M.D.
Affiliations: | Georgia Pediatric Pulmonary Associates, Atlanta, United States |
Google:
"Jonathan Popler"Parents
Sign in to add mentor| Frank J. Accurso | fellowship/program director | 2007-2010 | Children's Hospital Colorado |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Popler J, Vece TJ, Liptzin DR, et al. (2022) Pediatric pulmonology 2021 year in review: Rare and diffuse lung disease. Pediatric Pulmonology |
| Vece TJ, Popler J, Gower WA. (2021) Pediatric pulmonology 2020 year in review: Rare and diffuse lung disease. Pediatric Pulmonology |
| Koumbourlis AC, Belessis Y, Cataletto M, et al. (2020) Care Recommendations for the Respiratory Complications of Esophageal Atresia-Tracheoesophageal Fistula The International Network of Esophageal Atresia, Respiratory Complications Working Group. Pediatric Pulmonology |
| DeBoer EM, Wagner BD, Popler J, et al. (2018) Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid. Proteomics. Clinical Applications. e1800085 |
| Record E, Williamson R, Wasilewski-Masker K, et al. (2016) Analysis of Risk Factors for Abnormal Pulmonary Function in Pediatric Cancer Survivors. Pediatric Blood & Cancer |
| Bickel S, Popler J, Lesnick B, et al. (2014) Impulse oscillometry: interpretation and practical applications. Chest. 146: 841-7 |
| Popler J, Wagner BD, Tarro HL, et al. (2013) Bronchoalveolar lavage fluid cytokine profiles in neuroendocrine cell hyperplasia of infancy and follicular bronchiolitis. Orphanet Journal of Rare Diseases. 8: 175 |
| Kerby GS, Wagner BD, Popler J, et al. (2013) Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy. Pediatric Pulmonology. 48: 1008-15 |
| Popler J, Lesnick B, Dishop MK, et al. (2012) New coding in the International Classification of Diseases, Ninth Revision, for children's interstitial lung disease. Chest. 142: 774-80 |
| Popler J, Alimohammadi M, Kämpe O, et al. (2012) Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab. Pediatric Pulmonology. 47: 84-7 |